Zobrazeno 1 - 2
of 2
pro vyhledávání: '"C. M. Mullin"'
Autor:
Craig A. Clifford, M. L. Sauerbrey, S. S. Correa, B. A. Marker, T. A. LaDue, Lisa G. Barber, C. C. Wood, P. L. Thalhofer, C. M. Mullin
Publikováno v:
Veterinary and Comparative Oncology. 15:470-480
Pamidronate is a bisphosphonate drug widely utilized in veterinary oncologic practice for the palliation of malignant osteolysis. Pamidronate has not been previously reported to cause tissue injury upon extravasation in dogs. The medical records of 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91822feca708a4f2eb7c9827bd261e08
https://doi.org/10.1111/vco.12191
https://doi.org/10.1111/vco.12191
Autor:
C M, Mullin, M A, Arkans, C D, Sammarco, D M, Vail, B M, Britton, K R, Vickery, R E, Risbon, J, Lachowicz, K E, Burgess, C A, Manley, C A, Clifford
Publikováno v:
Veterinary and comparative oncology. 14(4)
Sixty-four dogs were treated with single-agent doxorubicin (DOX) for presumptive cardiac hemangiosarcoma (cHSA). The objective response rate (CR + PR) was 41%, and the biologic response rate (CR + PR + SD), or clinical benefit, was 68%. The median pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f9fed54a1227eed5e37292d4eccdf7d
https://pubmed.ncbi.nlm.nih.gov/25524594
https://pubmed.ncbi.nlm.nih.gov/25524594